A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/7068 (2006.01) A61K 9/20 (2006.01) A61K 9/48 (2006.01) A61K 31/522 (2006.01) A61K 31/7056 (2006.01) A61K 31/7072 (2006.01) A61P 31/20 (2006.01)
Patent
CA 2637774
A method for the treatment of a host, and in particular, a human, infected with HBV is provided that includes administering an HBV-treatment amount of a nucleoside of formula (I), (II) or (III), wherein R1 is hydrogen, fluoro, bromo, chloro, iodo, methyl or ethyl; and R2 is OH, Cl, NH2, or H; or a pharmaceutically acceptable salt of the compound, optionally in a pharmaceutically acceptable carrier or diluent.
L'invention porte sur une méthode de traitement d'un hôte, en particulier l'humain, infecté par le VHB. Le traitement comprend l'administration d'un traitement anti-VHB constitué d'une certaine quantité d'un nucléoside présentant la formule (I), (II) ou (III), où R1 est un hydrogène, un fluor, un brome, un chlore, un iode, un groupe méthyle ou éthyle; et R2 est un OH, un Cl, un NH2 ou un H; ou un sel pharmaceutiquement acceptable du composé, facultativement dans un diluant ou un vecteur pharmaceutiquement acceptable.
Gosselin Giles
Imbach Jean-Louis
Schinazi Raymond F.
Sommadossi Jean-Pierre
Centre National de La Recherche Scientifique (cnrs)
Centre National de La Recherche Scientifique - Cnrs
Emory University
Gowling Lafleur Henderson Llp
The Uab Research Foundation
LandOfFree
Nucleosides with anti-hepatitis b virus activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleosides with anti-hepatitis b virus activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleosides with anti-hepatitis b virus activity will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1432844